Drug approvals boost Japanese migraine treatment online | Healthcare Asia Magazine
, Japan

Drug approvals boost Japanese migraine treatment online

Some players have been highly active in digital channels of various countries.

Although digital activity in Japan’s migraine treatment landscape has not been prominent in the country until recently, it is expected to evolve with recent drug approvals, according to a report from GlobalData.

The market size of migraine in Japan is estimated to grow at a compound annual growth rate of 7.97% from $165m in 2021 to $365m in 2029. The landscape is growing with the recent approval of calcitonin gene-related peptide (CGRP) inhibitors as a preventative treatment.

Under the acute treatment market, triptans are the most prescribed drugs and account for most of the sales. However, they have all lost patent protection and are highly genericized across all the major markets. In the preventative market, the most prescribed drugs are beta-blockers while CGRP inhibitors represent the novel class.

Some players in the market have been highly active across digital channels of various countries to promote themselves and offer support to patients and healthcare providers, noted GlobalData’s pharma analyst Venkat Kartheek Vale.

Thus, successful implementation of this strategy in Japan will help companies position their products strongly against each other, Vale said.

However, a lack of diagnostic tools for identifying migraines has been a challenge for physicians to make an accurate and fast diagnosis, showing a need for greater awareness of the indication by healthcare providers to follow an effective treatment approach.

Still, the migraine treatment market is expected to rise with the launch of recent anti-CGRPs and few other novel molecules in the late-stage pipeline, Vale said.

Follow the link for more news on

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!


CHI accelerates the development and adoption of health tech firm innovations
The Centre for Healthcare Innovation invests $2.4m (US1.8m) to set a framework that can test the safety of market-ready innovations.
Catholic Medical Center trailblazing big data and AI adoption in Korean healthcare
Its flagship Seoul St. Mary’s Hospital leads the seamless integration of cutting-edge technology across CMC’s eight affiliate hospitals.
OUE Healthcare poised to capture foreign patient demand for specialist care services
The healthcare group recently partnered with three medical specialist groups including two leading respiratory and cardiothoracic surgery specialist practices.
iClaim boosts Thailand’s health insurance claims in 10 seconds
IT expert Piyawat Maneenual sets up a game-changing platform that allows data transfer from hospitals to insurance companies in real-time.